Published Date : Apr 18, 2017
ALBANY, New York, April 18, 2017 – The global cardiac markers rapid tests and point of care (POC) market has been anticipated to widen its pool of growth opportunities on account of noteworthy technological advances and the drive to upgrade patient care and refine its efficiency. In a report included by MarketResearchReports.biz in its medical equipment archive, the analysts have suggested manufacturers to focus on exhibiting the clinical value of their products to increase adoption by physicians. The analysts have also recommended players to count on strategies that work toward the accomplishment of present unmet needs. The report bears the title “MediPoint: Cardiac Markers Rapid Tests and Point Of Care - Global Analysis and Market Forecasts.”
The world cardiac markers rapid tests and POC market has been prophesied to receive strength with the advantage of fast turnaround time and clinical laboratory improvement amendments of 1988 (CLIA)-waived status of point-of-care testing (POCT). The augmented uptake of d-dimer testing and application of POC troponin test in a pre-hospital environment could raise the growth expectation of players operating in the market. Besides this, the surging prevalence of diseases diagnosed with cardiac markers rapid tests and POCT has been predicted to set the tone for the market.
The authors of the report have researched the global cardiac markers rapid tests and POC market to be negatively impacted by the competition with laboratory tests and adoption of innovative biomarkers. The management of POCT and interference in conventional ways of working could also impede the growth of the market. Other deterrents that have been expected to be functional in the market are cost and reimbursement and regulatory compliance.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/1026615
However, opportunities to maintain the current position in the international cardiac markers rapid tests and POC market could arise in the form of unmet in vitro diagnostics (IVD) needs and enhanced reliability of tests even outside of controlled testing environments. Moreover, data management benefits and help with the markers for myocardial ischemia could create new opportunities for players functioning in the market. The popularity of cardiac markers rapid tests and POCT has been envisaged to gain impetus from improved patient outcomes and strong evidences of cost-effectiveness.
The report complied on the global cardiac markers rapid tests and POC market has concentrated on 15 different regions, viz. Australia, South Korea, Russia, Mexico, Canada, Brazil, India, China, Japan, the U.K., Spain, Italy, Germany, France, and the U.S. If the companies assessed are concerned, Trinity Biotech, Siemens Healthineers, Roche Diagnostics, Response Biomedical, Radiometer Medical, Philips Healthcare, LSI Medience, Alere, and Abbott Point of Care are the nine players that have caught the eyes of the analysts. Along with their portfolio assessment, these players have been examined according to SWOT reports. Other vital factors pertaining to the competitive landscape of the market have also been explored in the report.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com